List of redirects

Jump to navigation Jump to search

Showing below up to 50 results in range #27,871 to #27,920.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. IIb/IIIa → 2b3a
  2. IIb/IIIa blocker → Glycoprotein IIb/IIIa inhibitors
  3. IIb/IIIa inhibitor → Glycoprotein IIb/IIIa inhibitors
  4. IIbIIIa blocker → Glycoprotein IIb/IIIa inhibitors
  5. IIbIIIa inhibitor → Glycoprotein IIb/IIIa inhibitors
  6. IKAP protein → IKBKAP
  7. IL-10 → Interleukin 10
  8. IL-11 → Interleukin 11
  9. IL-12 → Interleukin 12
  10. IL-13 → Interleukin 13
  11. IL-15 → Interleukin 15
  12. IL-16 → Interleukin 16
  13. IL-2 → Interleukin 2
  14. IL-21 → Interleukin 21
  15. IL-27 → Interleukin 27
  16. IL-4 → Interleukin 4
  17. IL-5 → Interleukin 5
  18. IL-6 → Interleukin 6
  19. IL-7 → Interleukin 7
  20. IL-7 receptor → Interleukin 7
  21. IL-8 → Interleukin 8
  22. IL-9 → Interleukin 9
  23. IL10RB → Interleukin 10 receptor, beta subunit
  24. IL11RA → Interleukin 11 receptor alpha subunit
  25. IL12RB1 → Interleukin 12 receptor, beta 1 subunit
  26. IL12RB2 → Interleukin 12 receptor, beta 2 subunit
  27. IL15RA → Interleukin 15 receptor, alpha subunit
  28. IL1R1 → Interleukin 1 receptor, type I
  29. IL20RA → Interleukin 20 receptor, alpha subunit
  30. IL21R gene → IL21R
  31. IL5RA → Interleukin 5 receptor alpha subunit
  32. IL6R → Interleukin-6 receptor
  33. IL8RA → Interleukin 8 receptor, alpha
  34. IL9R → Interleukin-9 receptor
  35. ILD → Interstitial lung disease
  36. ILLUMINATE → Investigation Of Lipid Level Management To Understand Its Impact In Atherosclerotic Events
  37. ILLUMINATE trial → ILLUMINATE Trial
  38. ILLUSTRATE → Investigation Of Lipid Level Management Using Coronary Ultrasound To Assess Reduction Of Atherosclerosis By Cetp Inhibition And Hdl Elevation
  39. IMAGES → Intravenous Magnesium Efficacy In Stroke
  40. IMAGINE reported: early ACE inhibitor therapy in low risk CABG patients associated with worse early outcomes → Special:Badtitle/NS100:IMAGINE reported: early ACE inhibitor therapy in low risk CABG patients associated with worse early outcomes
  41. IMI → Innovative Medicines Initiative
  42. IMPACT → Integrilin To Manage Platelet Aggregation To Prevent Coronary Thrombosis International Mexiletine Or Placebo Antiarrhythmic Coronary TrialInternational Multiple Sclerosis Secondary Progressive Avonex Controlled Trial
  43. IMPACT-HF → Initiation Management Predischarge: Process For Assessment Of Carvedilol Therapy In Heart Failure
  44. IMPACT II → Integrilin To Minimise Platelet Aggregation And Coronary Thrombus - II
  45. IMPROVE-CHF → Improved Management Of Patients With Congestive Heart Failure
  46. IMPROVEDD → IMPROVEDD VTE risk score
  47. IMPROVEDD risk score → IMPROVEDD risk score calculator
  48. IMPROVEDD risk score calculator → IMPROVEDD VTE risk score
  49. IMPROVEDD score → IMPROVEDD VTE risk score
  50. IMPROVED score → IMPROVEDD risk score calculator

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://www.wikidoc.org/index.php/Special:ListRedirects"